BOULDER, Colo., Feb. 6, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Leerink Swann Healthcare Conference in New York. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)
Event: | Leerink Swann Healthcare Conference |
Presenter: | Ron Squarer, Chief Executive Officer |
Date: | Wednesday, February 12, 2014 |
Time: | 10:15 a.m. Eastern Time |
Location: | The Waldorf Astoria, New York, NY |
Webcast: |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Seven Phase 3 or pivotal studies are already in progress, or are planned to begin, within the next year. These programs include the wholly-owned hematology drug, filanesib (ARRY-520), for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (Novartis). For more information on Array, please go to www.arraybiopharma.com
CONTACT: | Tricia Haugeto |
Array BioPharma Inc. | |
303-386-1193 | |
SOURCE Array BioPharma Inc.
Help employers find you! Check out all the jobs and post your resume.
